Finance

Lists
Why is ANTX down 5,98%?
Dive Deeper
ANTX:NASDAQ
AN2 Therapeutics Inc
4,40 $
-5,98%
(-0,28) 1D
4,48 $
+1,82% (+0,080)
After hours
Closed: 9 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANTX...
Open
4,65 $
High
4,67 $
Low
4,26 $
Mkt. cap
166,04 млн
Avg. vol.
264,57 м.
Volume
442,13 м.
52-wk high
7,19 $
52-wk low
1,00 $
EPS
-1,07 $
Beta
-0,98
Shares outstanding
37,74 млн
No. of employees
21
Open
4,65 $
High
4,67 $
Low
4,26 $
Mkt. cap
166,04 млн
Avg. vol.
264,57 м.
Volume
442,13 м.
52-wk high
7,19 $
52-wk low
1,00 $
EPS
-1,07 $
Beta
-0,98
Shares outstanding
37,74 млн
No. of employees
21
News stories
From web sources and news partners
About AN2 Therapeutics Inc
CEO-
Employees21
Founded2017
HeadquartersMenlo Park, Калифорния, Америка Құрама Штаттары
SectorPharmaceutical industry
Websitean2therapeutics.com
Analyst ratings
Based on 1 analyst giving stock ratings to ANTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ANTX in the last 3 months
Highest
Current 4,40 $
9,00 $ (+104,55%)
Average
9,00 $ (+104,55%)
Lowest
9,00 $ (+104,55%)
Analyst
Recommendation
Action
Price target
Projected
Date
Bradley Canino
Guggenheim
Buy
Initiated
9,00 $
+104,5%
07/19/2026
Joseph Schwartz
Leerink Partners
Buy
Upgraded
9,00 $
+104,5%
05/15/2026
Last report
2026 ж. 11 там.
Fiscal period
Q2 2026
-0,18 $ / -0,24 $
+25,00%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,00 млн
6,88 млн
6,74 млн
6,02 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,04 млн
2,44 млн
3,81 млн
2,88 млн
Operating expense
10,04 млн
9,32 млн
10,55 млн
8,90 млн
Total operating expenses
10,04 млн
9,32 млн
10,55 млн
8,90 млн
Operating income
-10,04 млн
-9,32 млн
-10,55 млн
-8,90 млн
Other non operating income
-
1,00 мың
-
-1,00 мың
EBT including unusual items
-9,35 млн
-8,71 млн
-10,03 млн
-8,18 млн
EBT excluding unusual items
-9,35 млн
-8,71 млн
-10,03 млн
-8,18 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,35 млн
-8,71 млн
-10,03 млн
-8,18 млн
Net profit margin
-
-
-
-
Earnings per share
-0,31
-0,29
-0,29
-0,18
Interest and investment income
687,00 м.
605,00 м.
523,00 м.
720,00 м.
Interest expense
-
-
-
-
Net interest expenses
687,00 м.
605,00 м.
523,00 м.
720,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары